Investigational Site Number 8011 — Philadelphia, Pennsylvania

Investigational Site Number 8011 is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 8011 has participated in 1 clinical trials.

Therapeutic areas: Hyperphosphatemia, Chronic Kidney Disease.

Sponsors: Genzyme, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 8011?

Investigational Site Number 8011 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 8011 conducted?

Investigational Site Number 8011 has 1 clinical trials on record. Their work covers Hyperphosphatemia, Chronic Kidney Disease.

Is Investigational Site Number 8011 accredited by Crixeo Health?

Investigational Site Number 8011 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 8011?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.